Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan Effect on Coronary Plaque in Hypertensive Patients with Stable Angina and Dyslipidemia
jRCT1080222782
- Sponsor
- Takeda
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of azilsartan in essential hypertension, stable angina, dyslipidemia and 1 more, sponsored by Takeda.
02
Drugs
azilsartan
03
Conditions
essential hypertensionstable anginadyslipidemiacoronary arteriosclerosis
Beyond the preview
Go deeper on jRCT1080222782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222782.